Equity (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Summarizes the Aggregate Number of Stock Options And Restricted Stock Unit

The following table summarizes the aggregate number of stock options and restricted stock units, or RSUs, outstanding under the 2020 Plan as of December 31, 2022:

	December 31, 2022
Outstanding stock options		19,182,111
% of outstanding shares on a fully diluted basis		4	%
Outstanding RSUs		14,461,050
% of outstanding shares on a fully diluted basis		3	%

Summary of Equity Awards Activity

The following table represents equity awards activity during the years ended December 31, 2022 and 2021:

	For the Year Ended December 31,
	2022		2021
Common shares issued for stock option exercises		33,303		1,203,845
Gross and net proceeds from stock option exercises	$	59,686	$	2,921,000
Common shares issued in settlement of vested RSUs		1,940,371		1,203,845
Shares retained for settlement of employee tax obligations ─ RSUs		500,064		782,917
Common shares issued in settlement of vested Performance-Based RSUs (1)		—		1,923,316
Shares retained for settlement of employee tax obligations ─ Performance-Based RSUs		—		816,931

(1)Performance-based RSUs vested in connection with the achievement of certain regulatory and sales performance conditions associated with the REDUCE-IT clinical trial and subsequent revenue growth. These performance-based RSUs have fully vested as of August 2021.